Approval · Notice of Compliance 21384 · 2018
VELTASSA: Notice of Compliance 21384
Issued October 3, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21384
- Date
- October 3, 2018
- Company
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- PATIROMER SORBITEX CALCIUM 8.4 G per PCK
- PATIROMER SORBITEX CALCIUM 16.8 G per PCK
- PATIROMER SORBITEX CALCIUM 25.2 G per PCK